Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net income attributable to common shareholders	$ (2,528,124)	$ 569,281
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	178,699	(658,331)
Realized investment gains, net	(544,060)	(4,067,797)
Unrealized trading (gains) losses included in income	111,531	(39,476)
Realized trading (gains) included in income	(110,470)	0
Amortization of cost of insurance acquired	419,553	436,492
Depreciation	349,582	412,472
Net income (loss) attributable to noncontrolling interest	(95,602)	45,973
Charges for mortality and administration of universal life and annuity products	(3,324,867)	(1,107,778)
Interest credited to account balances	2,181,552	867,663
Change in accrued investment income	330,290	(101,071)
Change in reinsurance receivables	169,621	160,739
Change in policy liabilities and accruals	(321,400)	(1,764,350)
Change in income taxes receivable (payable)	(75,074)	(133,218)
Change in other assets and liabilities, net	(1,153,065)	(1,701,843)
Net cash used in operating activities	(4,411,834)	(7,081,244)
Proceeds from investments sold and matured:
Fixed maturities available for sale	9,585,460	21,633,273
Equity securities available for sale	2,126,149	1,195,793
Trading securities	0	72,279
Mortgage loans	562,792	2,000,374
Real estate	5,083,776	8,002,596
Notes receivable	305,874	2,682,590
Policy loans	1,087,870	1,300,996
Total proceeds from investments sold and matured	18,751,921	36,887,901
Cost of investments acquired:
Fixed maturities available for sale	(7,141,692)	(6,139,596)
Equity securities available for sale	(2,424,875)	(1,463,409)
Trading securities	0	(70,690)
Mortgage loans	(354,306)	(2,694,686)
Real estate	(1,678,891)	(8,668,777)
Notes receivable	(2,047,853)	(7,047,843)
Policy loans	(782,464)	(1,182,883)
Total cost of investments acquired	(14,430,081)	(27,267,884)
Net cash provided by investing activities	4,321,840	9,620,017
Cash flows from financing activities:
Policyholder contract deposits	2,470,129	772,689
Policyholder contract withdrawals	(2,838,813)	(594,960)
Payments of principal on notes payable/line of credit	(1,450,000)	0
Purchase of treasury stock	(8,692)	(455,645)
Non controlling contributions (distributions) of consolidated subsidiary	(732,752)	(49,893)
Net cash used in financing activities	(2,560,128)	(327,809)
Net increase in cash and cash equivalents	(2,650,122)	2,210,964
Cash and cash equivalents at beginning of period	15,156,548	11,822,615
Cash and cash equivalents at end of period	$ 12,506,426	$ 14,033,579